Skartun O, Smith CR, Laupsa-Borge J, Dankel SN
Glucagon-Like Peptide-1 Receptor Agonist Medications and Hair Loss: A Retrospective Cohort Study
See a healthcare provider immediately if you experience: An inability to eat Persistent or severe nausea that impacts your daily life Signs of dehydration (extreme thirst, dizziness, dry mouth, peeing less often) If your nausea is severe, consult with your prescribing physician or your GI team
More than 80% achieved at least 15% weight loss, supporting ongoing investigation in pharmacologic obesity management
Patients interested in retatrutide for any clinical reason would need to enrol in one of the active TRIUMPH Phase 3 trials through Eli Lilly's investigator network
Consult with a board-certified aesthetic expert (plastic surgeon or dermatologist) to explore your options